Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?

Autoimmunity Reviews

Volumn 9, Issue 10, 2010, Pages 684-686

  Zardi, Enrico M ^a   Afeltra, Antonella ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Atherosclerosis (ATS); Color Doppler sonography; Endothelial dysfunction; Inflammation; Intima media thickness (IMT); Systemic lupus erythematosus (SLE); Vascular stiffness

Indexed keywords

ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTERY DILATATION; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COLOR ULTRASOUND FLOWMETRY; EARLY DIAGNOSIS; ENDOTHELIAL DYSFUNCTION; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; M MODE ECHOCARDIOGRAPHY; OXIDATIVE STRESS; PULSE WAVE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 77955280276     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.05.018     Document Type: Review

References (43)

1. Rhew E.Y., Ramsey-Goldman R. Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms. Autoimmun Rev 2006, 5(2):101-105.
2. Westerweel P.E., Luyten R.K., Koomans H.A., et al. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum 2007, 56(5):1384-1396.
3. Sherer Y., Zinger H., Shoenfeld Y. Atherosclerosis in systemic lupus erythematosus. Autoimmunity 2010, 43(1):98-102.
4. Bassi N., Ghirardello A., Iaccarino L., et al. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. Autoimmun Rev 2007, 7(1):52-58.
5. Ben Mansour R., Lassoued S., Gargouri B., et al. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 2008, 37(2):103-108.
6. Ben Mansour R., Lassoued S., Elgaied A., et al. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol 2010, 39(3):247-253.
7. Rajaiah R., Moudgil K.D. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 2009, 8(5):388-393.
8. Perl A. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity 2010, 43(1):1-6.
9. Hahn B.H., Grossman J., Chen W., et al. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 2007, 28(2-3):69-75.
10. Matsuura E., Lopez L.R. Autoimmune-mediated atherothrombosis. Lupus 2008, 17(10):878-887.
11. Matsuura E., Kobayashi K., Lopez L.R. Atherosclerosis in autoimmune diseases. Curr Rheumatol Rep 2009, 11(1):61-69.
12. Amaral M.C., Alves J.D. Pathogenesis of multi-organic failure in autoimmune diseases. Autoimmun Rev 2009, 8(6):525-528.
13. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340(8828):1111-1115.
14. Karp I., Abrahamowicz M., Fortin P.R., et al. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?. Arthritis Rheum 2008, 59(2):169-175.
15. Abu-Shakra M., Codish S., Zeller L., et al. Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience. Isr Med Assoc J 2008, 10(1):43-44.
16. Roman M.J., Devereux R.B., Schwartz J.E., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005, 46(1):194-199.
17. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37(5):1236-1241.
18. Shang Q., Tam L.S., Li E.K., et al. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus 2008, 17(12):1096-1102.
19. Delles C., Zimmerli L.U., McGrane D.J., et al. Vascular stiffness is related to superoxide generation in the vessel wall. J Hypertension 2008, 26(5):946-955.
20. Chouinard J.A., Grenier G., Khalil A., et al. Oxidized-LDL induce morphological changes and increase stiffness of endothelial cells. Exp Cell Res 2008, 314(16):3007-3016.
21. Chow P.C., Ho M.H., Lee T.L., et al. Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol 2007, 34(6):1345-1352.
22. Sitia S., Atzeni F., Sarzi-Puttini P., et al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 2009, 8(4):281-286.
23. Nadar S., Blann A.D., Lip G.Y. Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des 2004, 10(29):3591-3605.
24. Vita J.A., Keaney J.F., Larson M.G., et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 2004, 110(23):3604-3609.
25. Franklin S.S. Arterial stiffness: is it ready for prime time?. Curr Cardiol Rep 2007, 9(6):462-469.
26. Huck C.J., Bronas U.G., Williamson E.B., et al. Noninvasive measurements of arterial stiffness: repeatability and interrelationships with endothelial function and arterial morphology measures. Vasc Health Risk Manag 2007, 3(3):343-349.
27. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27(21):2588-2605.
28. Cacciapaglia F., Zardi E.M., Coppolino G., et al. Stiffness parameters, intima-media thickness and early atherosclerosis in sistemic lupus erythematosus patients. Lupus 2009, 18(3):249-256.
29. Thompson T., Sutton-Tyrrell K., Wildman R.P., et al. Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 2008, 58(3):835-482.
30. Hashimoto H., Tagaya M., Niki H., et al. Computer-assisted analysis of heterogeneity on B-mode imaging predicts instability of asymptomatic carotid plaque. Cerebrovasc Dis 2009, 28(4):357-364.
31. Stein J.H., Korcarz C.E., Hurst R.T., et al. Use of carotid ultrasound to identify preclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21(2):93-111.
32. Tyrrell P.N., Beyene J., Feldman B.M., et al. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2010, 30(5):1014-1026.
33. Colombo B.M., Cacciapaglia F., Puntoni M., et al. Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). Autoimmun Rev 2009, 8(4):309-315.
34. Roman M.J., Salmon J.E. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008, 121(10 Suppl 1):S3-S8.
35. Doria A. Atherosclerosis and lupus: what we know and what we should know. J Rheumatol 2009, 36(11):2380-2382.
36. van Popele N.M., Grobbee D.E., Bots M.L., et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001, 32(2):454-460.
37. Nurmohamed M.T. Cardiovascular risk in rheumatoid arthritis. Autoimmun Rev 2009, 8(8):663-667.
38. Rho Y.H., Chung C.P., Oeser A., et al. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. J Rheumatol 2008, 35(9):1789-1794.
39. Sandborg C., Ardoin S.P., Schanberg L. Therapy insight: cardiovascular disease in pediatric systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008, 4(5):258-265.
40. Selzer F., Sutton-Tyrrell K., Fitzgerald S., et al. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001, 37(4):1075-1082.
41. Shenoy P., Agarwal V. Phosphodiesterase inhibitors in the management of autoimmune disease. Autoimmun Rev 2010, 9(7):511-515.
42. van Leeuwen M., Damoiseaux J., Duijvestijn A., et al. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis. Autoimmun Rev 2009, 9(1):53-57.
43. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115(10):1285-1295.